CGP57148B effectively inhibits the proliferation of lineage-committed and primitive chronic myelogenous leukemia progenitors

被引：0
|
作者：
Fruehauf, S
Kasper, B
Schiedlmeier, B
Buchdunger, E
Zeller, WJ
机构：
[1] Univ Heidelberg, Dept Internal Med 5, D-69115 Heidelberg, Germany
[2] German Canc Res Ctr, DFKZ, Dept 0420, D-69120 Heidelberg, Germany
[3] Novartis, Oncol Res Dept, CH-4002 Basel, Switzerland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 10 条
  • [1] Purging of lineage-committed and primitive chronic myelogenous leukemia (CML) progenitors using the tyrosine kinase inhibitor CGP57148b (CGP).
    Fruehauf, S
    Kasper, B
    Schiedlmeier, B
    Buchdunger, E
    Ho, AD
    Zeller, WJ
    BLOOD, 1998, 92 (10) : 244B - 244B
  • [2] Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors
    Bernd Kasper
    Stefan Fruehauf
    Bernd Schiedlmeier
    Elisabeth Buchdunger
    Anthony D. Ho
    W. Jens Zeller
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 433 - 438
  • [3] Favorable therapeutic index of a p210BCR-ABL-specific tyrosine kinase inhibitor;: activity on lineage-committed and primitive chronic myelogenous leukemia progenitors
    Kasper, B
    Fruehauf, S
    Schiedlmeier, B
    Buchdunger, E
    Ho, AD
    Zeller, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (05) : 433 - 438
  • [4] The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors
    Hromas, R
    Cripe, L
    Hangoc, G
    Cooper, S
    Broxmeyer, HE
    BLOOD, 2000, 95 (04) : 1506 - 1508
  • [5] Gleevec (STI571) selectively inhibits growth of chronic myelogenous leukemia primitive progenitors through reversal of abnormally increased proliferation.
    Holtz, MS
    Slovak, ML
    Zhang, FY
    Sawyers, CL
    Forman, SJ
    Bhatia, R
    BLOOD, 2001, 98 (11) : 618A - 618A
  • [6] Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation
    Holtz, MS
    Slovak, ML
    Zhang, FY
    Sawyers, CL
    Forman, SJ
    Bhatia, R
    BLOOD, 2002, 99 (10) : 3792 - 3800
  • [7] Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation
    Bhatia, R
    Munthe, HA
    Williams, AD
    Zhang, F
    Forman, SJ
    Slovak, ML
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (12) : 1401 - 1412
  • [8] Chronic myelogenous leukemia CD34(+) marrow cells lacking CD95 expression are enriched for BCR/ABL negative primitive and committed progenitors.
    CarloStella, C
    Savoldo, B
    Regazzi, E
    Garau, D
    Sammarelli, G
    Mangoni, L
    Almici, C
    Frassoni, F
    Rizzoli, V
    BLOOD, 1996, 88 (10) : 2284 - 2284
  • [9] The dual SRC/ABL kinase inhibitor SKI-606 effectively inhibits BCR-ABL kinase activity in chronic myelogenous leukemia primitive progenitor cells.
    Sindhu, S.
    Koenig, H.
    Boschelli, F.
    Holyoake, T. L.
    Forman, S. J.
    Bhatia, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S141 - S141
  • [10] Deletion of Rac2 inhibits Proliferation of Chronic Myelogenous Leukemia (CML) Stems Cells and Progenitors (HSC/P) In Vivo and Promotes Survival of Scl/p210-BCR-ABL Mice
    Sengupta, Amitava
    Arnett, Jorden
    Dunn, Susan
    Cancelas, Jose
    BLOOD, 2009, 114 (22) : 1260 - 1260
1